FDA’s Vaccine Panel to Weigh XFG Variant for New COVID Shots

MedPage Today) — The FDA’s vaccine advisors will meet Thursday to vote on whether an XFG monovalent vaccine should be preferred for COVID-19 shots for the 2026-2027 season.
The Vaccines and Related Biological Products Advisory Committee (VRBPAC…
Read More

About The Author

Jonathan Jeriah

See author's posts